A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Study ID
- NCT07698314
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Breast Cancer
- Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 20 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Conditioning Resistance Training — BEHAVIORALParticipants in this group will perform a conditioning regimen from the EXERT-BCHC protocol, specifically described as "double training".
- Strength Resistance Training — BEHAVIORALParticipants in this group will perform a strength regimen from the EXERT-BCHC protocol, specifically described as "8x8".
- Hypertrophy Resistance Training — BEHAVIORALParticipants in this group will perform a hypertrophy regimen from the EXERT-BCHC protocol, specifically described as the "control arm".
Study Details
In this pilot study, the investigators will assess the changes in myokine production based on several different exercise regimens.
Key Dates
- First listed
- Jul 13, 2026
- Start date
- Jun 30, 2026
- Status verified
- Jul 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 21 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Conditioning Regimen Group
- Experimental: Strength Regimen Group
- Experimental: Hypertrophy Regimen Group
Primary Outcome Measure
Change in Myokine Production After First Exercise Session [ Time Frame: Immediately before and immediately after the first exercise session. ]
Central Contacts
- Clinical Trials Contact412-330-6151
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| AHN Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 |
Find similar trials in Pittsburgh, PA
By condition
By specialty
By research site
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and SerumRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Cardiotoxicity of Cancer Therapy (CCT)Enrolling By Invitation · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania